Hussman Strategic Advisors’s Select Medical SEM Stock Holding History

Hussman Strategic Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-126,000	Closed	-$2.38M	–	312
2024 Q4	$2.38M	Buy	+126,000	New	+$2.43M	0.7%	39
2020 Q3	–	Sell	-238,496	Closed	-$1.89M	–	304
2020 Q2	$1.89M	Buy	238,496 +2,784	+1%	+$23.1K	0.48%	80
2020 Q1	$1.91M	Buy	+235,712	New	+$2.8M	0.51%	64
2019 Q2	–	Sell	-10,208	Closed	-$77K	–	242
2019 Q1	$77K	Hold	10,208	–	–	0.02%	205
2018 Q4	$84K	Sell	10,208 -139,200	-93%	-$1.33M	0.02%	206
2018 Q3	$1.48M	Sell	149,408 -46,400	-24%	-$480K	0.43%	104
2018 Q2	$1.92M	Hold	195,808	–	–	0.52%	88
2018 Q1	$1.82M	Buy	195,808 +185,600	+1,818%	+$1.77M	0.5%	99
2017 Q4	$97K	Hold	10,208	–	–	0.03%	133
2017 Q3	$106K	Hold	10,208	–	–	0.03%	147
2017 Q2	$84K	Hold	10,208	–	–	0.02%	154
2017 Q1	$73K	Buy	+10,208	New	+$74K	0.02%	166

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hussman Strategic Advisors's SEM Position: Q1 2025 in Review

Hussman Strategic Advisors sold out of Select Medical (SEM) in Q1 2025, closing a stake of 126,000 shares — an estimated $2.38M sold.

Hussman Strategic Advisors first reported a position in SEM in Q1 2017 and held it in 12 quarters. The position peaked at $2.38M in Q4 2024. 274 funds tracked by Wall St. Rank hold SEM as of Q1 2025.

Hussman Strategic Advisors reported no remaining Select Medical position as of Q1 2025 after selling out during the quarter.
Hussman Strategic Advisors sold 126,000 Select Medical shares in Q1 2025, an estimated $2.38M.
Hussman Strategic Advisors first reported a position in Select Medical in Q1 2017 and held it in 12 quarters.
Hussman Strategic Advisors's Select Medical position peaked at $2.38M in Q4 2024.
274 funds tracked by Wall St. Rank held Select Medical as of Q1 2025.

Based on Hussman Strategic Advisors's 13F filing for Q1 2025, filed 5 May 2025.